Floatz logo

Lentivirus Vector CCR5 shRNA

Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma

AIDS Malignancy ConsortiumPhase 1/2Active
CC
45/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
33/ 100
Competitive Position
81/ 100

Competitive context

35 Active assets in the Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma cohort.

Asset / SponsorPhaseRating
ETOPOSIDE
Alliance for Clinical Trials in Oncology
Phase 4BB
Cyclophosphamide
City of Hope Medical Center
Phase 2BB
DEXAMETHASONE
Zhengzhou University
Phase 4BB
Inno-206
City of Hope Medical Center
Phase 2BB
PREDNISONE TABLETS
City of Hope Medical Center
Phase 2BB

View all 50 →

Same molecule, other indications

Lentivirus Vector CCR5 shRNA is also rated in:

non-Hodgkin lymphomaDormant
CCC
Indicative ·
48 / 100
View asset →
Hodgkins lymphomaDormant
CCC
Indicative ·
48 / 100
View asset →
Burkitt lymphomaDormant
CCC
Indicative ·
48 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →